Aquestive Therapeutics AQST
NASDAQ AQST
$3.63 +0.11 (+3.13%)
As of: Nov 11, 2026 · 12:40 PM EST

Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2020 - 2021)

Updated

Aquestive Therapeutics' Long-Term Debt Issuances came in at $31.14 million for FY2023.

Analysis

Aquestive Therapeutics (AQST) Long-Term Debt Issuances (2020 - 2021) Analysis & Trends

Going back to FY2017, Aquestive Therapeutics' Long-Term Debt Issuances data covers 4 years.

  • Long-Term Debt Issuances carries a four-year compound annual growth rate of -18.3% (FY2019 to FY2023).
  • The FY2023 figure represents the highest annual Long-Term Debt Issuances since FY2020.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $50 million in FY2020 (-28.6%) and $70 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 9.98 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Aquestive Therapeutics 442.42 Mn 21.68 Mn 3.95 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 4.00 Mn
Dec 31, 2020 50.00 Mn
API Access

Aquestive Therapeutics Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AQST&period=max&api_key=YOUR_API_KEY